A chordoma was removed from the tail base of a 6.5-year-old ferret (Mustela putorius furo). A nodule was observed in the area of tumor development when the ferret was purchased at 3 months of age. Although the nodule did not enlarge for 2 years, slow, steady growth of the tumor was observed for 4 years before surgical removal. Eight months after removal of the chordoma, the ferret developed 2 cutaneous masses. One was adjacent to the vulva, close to where the chordoma had been removed from, whereas the other was in the nasofacial region. After 4 months of slow growth, both masses were removed and both were histologically and immunohistochemically consistent with chordoma. Over the next 8 weeks, additional masses developed in the facial, maxillary gingival, and scapular regions. Enlargement of the gingival mass caused dysphagia, and the ferret was euthanized. Although a necropsy was not performed, these additional masses had a clinical appearance and texture that was similar to the 2 previously removed cutaneous chordomas. To the authors' knowledge, this is the first report of a ferret coccygeal chordoma that developed close to the base of the tail. Ferret chordomas have been reported previously to metastasize to the subcutis overlying the tumor. However, this is the first report of a ferret chordoma that metastasized to a location distant to the primary site of neoplasm development. Cell proliferation indices did not predict this metastatic behavior. It is hypothesized that the long clinical period before removal may have predisposed this neoplasm to metastasis. Observations from this case suggest that chordomas in ferrets may have metastatic potential and so should be removed promptly.
A 6.5-year-old spayed female domestic ferret (Mustela putorius furo) presented with a broad-based oblong 3-ϫ 5-ϫ 5-cm ulcerated mass at the base of the tail. The owner reported that a small nodule had been present in this area when the ferret was purchased at 3 months of age. However, the mass had reportedly not started to enlarge until the ferret was approximately 2.5 years of age, 4 years before initial presentation. The ferret was reported to be otherwise healthy, and the mass did not appear to cause irritation to the animal.
The mass was surgically removed by amputation of the tail around the level of the third coccygeal vertebra. Although the ferret developed transient fecal incontinence, presumably because of the level of the amputation, recovery was considered routine. The mass was fixed in 10% buffered formalin and submitted for histological examination. Immunohistochemistry was performed using formalin-fixed, paraffin-embedded sections. Antibodies against pancytokeratin, a vimentin, a proliferating cell nuclear antigen (PCNA), b and Ki-67 c were used. The avidin-biotin-peroxidase complex system d was used to observe all immunohistochemical reactions. Argyrophilic nucleolar organizer regions (AgNORs) were stained using a previously reported protocol. 6 Histological examination of the mass revealed a loosely packed, nodular, well-encapsulated neoplasm From the Athens Diagnostic Laboratory and Department of Veterinary Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. 1 Corresponding Author: John S. Munday, Athens Diagnostic Laboratory, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. that extended from the periosteum of the coccygeal vertebra to the superficial hypodermis. The neoplastic cells were arranged in large confluent lobules separated by a fibrovascular stroma. Extracellular amorphous basophilic material, interpreted as mucin, was visible within the center of approximately 20% of the lobules. Well-differentiated trabecular bone and cartilage comprised approximately 25% of the neoplasm (Fig. 1 ). Bone and cartilage tended to be located toward the center of the mass. The neoplastic cells were pleomorphic 15-25-m-diameter polyhedral cells with poorly defined cell borders. Cells within the center of the lobules were generally larger than those toward the periphery. The cytoplasm of the larger neoplastic cells was heavily vacuolated, and the nucleus was often displaced to the periphery (consistent with physaliphorous cells). The vacuoles contained amorphous lightly basophilic or nonstaining material. Cytoplasm of smaller neoplastic cells was lightly eosinophilic and slightly granular. All neoplastic cells had small round hyperchromatic nuclei. The mass was ulcerated, and approximately 5% of the neoplastic cells within superficial areas were necrotic. Neoplastic cells were visible within sections of the proximal aspect of the amputated tail and complete tumor excision could not be confirmed histologically. One mitotic figure was visible per ten 400ϫ fields. The neoplastic cells exhibited moderate to intense cytoplasmic staining using antibodies against pancytokeratin and vimentin. Pancytokeratin immunoreactivity was typically restricted to the periphery of the cytoplasm. In addition, staining with antipancytokeratin antibodies was more intense within the larger cells close to the center of lobules, whereas vimentin expression was observed more diffusely throughout the neoplastic cell population. Figure 2 . Ferret nasofacial cutaneous mass. A well-circumscribed encapsulated mass within the deep dermis is causing compression of an overlying hair follicle. Neoplastic cells are arranged within poorly defined lobules. Extracellular amorphous basophilic material that is interpreted as mucin is present within the mass (lower left). HE. 100ϫ. Figure 3 . Ferret nasofacial cutaneous mass. The neoplasm consists of cells that often contain large clear cytoplasmic vacuoles and small dark peripherally displaced nuclei (physaliferous cells). HE. 400ϫ. Figure 4 . Ferret nasofacial cutaneous mass. Neoplastic cells demonstrate strong immunoreactivity to antibodies against pancytokeratin. The immunoreactivity is generally confined to the periphery of the cytoplasm. Avidin-biotin-peroxidase complex system, Gill hematoxylin counterstain. 600ϫ. Figure 5 . Ferret nasofacial cutaneous mass. Neoplastic cells stain intensely using antivimentin antibodies. Vimentin immunoreactivity is distributed more widely throughout the cytoplasm. Avidin-biotin-peroxidase complex system, Gill hematoxylin counterstain. 600ϫ.
Eight months after the initial surgery, the ferret developed 2 skin masses. These enlarged slowly for 4 months at which time they were surgically removed. One mass was situated adjacent to the vulva and measured 2-ϫ 2-ϫ 2-cm, whereas the other developed in the nasofacial region and measured 1-ϫ 1-ϫ 1-cm. Both masses were described clinically as cystic and were pink. Both masses were fixed in 10% formalin and routinely processed for histological examination.
Both masses had a similar histological appearance. The masses were loosely packed, encapsulated, nodular, roughly spherical and located within the deep dermis. The larger mass extended to the epidermis and was focally ulcerated. The smaller mass was confined to the deeper layers of the dermis but was compressing overlying adnexal structures (Fig. 2) . Cells within the neoplasms were arranged within poorly defined lobules that were separated by a moderate fibrous stroma. Basophilic amorphous extracellular material, consistent with mucin, was present within some lobules. Both masses contained eosinophilic material that was interpreted as nonmineralized osteoid. Neither neoplasm contained bone or cartilage. Cells within both neoplasms were generally large and heavily vacuolated (consistent with physaliphorous cells) ( Fig. 3 ). One mitotic figure was visible per ten 400ϫ fields within both neoplasms. The nasofacial mass appeared completely excised with margins greater than 2 mm, whereas cells within the perivulval mass extended to the tissue margins. Similar to the mass removed from the tail base, cells within both neoplasms exhibited strong cytoplasmic reactivity to antibodies against both vimentin and pancytokeratin. As before, pancytokeratin reactivity was generally confined to the periphery of the cytoplasm (Fig. 4) , whereas vimentin expression was present more diffusely within the cells (Fig. 5 ). Histological appearance and immunohistochemical reactivity of these 2 cutaneous masses was consistent with a diagnosis of chordoma. Both masses were considered likely to be metastases of the chordoma that had been previously removed from the tail base.
Two weeks after the cutaneous metastases were removed, another cutaneous mass developed in the facial region. During the next 6 weeks, 3 more facial masses developed as well as a mass on the rostral aspect of the right maxillary gingiva and another on the left shoulder. These masses enlarged slowly. Although a biopsy was not performed, all 6 masses were described as having a similar clinical appearance and spongy texture to the previously removed cutaneous chordomas. The ferret remained alert and clinically healthy for 4 months. The ferret was euthanized when the gingival mass enlarged to an extent that it interfered with mastication. A necropsy was not performed.
Chordomas are neoplastic proliferations of noto-chord cells. 3 In the embryo, the notochord is the foundation for the developing axial skeleton. Once surrounded by the vertebral column, the notochord degenerates forming the nucleus pulposus within intervertebral disks. Residual notochord cell nests, predominantly within the sacral and occipital areas, occur in an estimated 2% of humans. 3 Chordomas are thought to develop from these residual cell rests rather than from the larger quantity of intervertebral disk notochord tissue. 3 Although chordomas have been reported in a variety of animal species, ferrets appear predisposed to developing tumors of this type. A retrospective survey of 533 ferret neoplasms submitted over a 10-year period to the University of Georgia Athens Veterinary Diagnostic Laboratory (AVDL), Athens, Georgia, revealed that chordomas constituted 5% of all neoplasms and 86% of all bone neoplasms. In humans, chordomas represent just 1-4% of primary malignant bone tumors. 3 Although most ferret chordomas develop at the tip of the tail, 1 thoracic 7 and cervical 11 chordomas have also been reported. To the authors' knowledge, the present report is the first description of a coccygeal chordoma in a ferret that developed close to the base of the tail. In humans, 50% of chordomas develop in the sacrococcygeal region, 35% in the basiocciput, and 15% within the remaining vertebrae. 8 Chordomas in ferrets are generally considered locally expansive tumors that have little metastatic potential. To the authors' knowledge, metastasis of a ferret coccygeal chordoma has not been reported previously. However, metastasis of a cervical chordoma in a ferret has been reported. This ferret developed a single metastasis in the subcutis adjacent to the neoplasm. 1 A study of 207 human patients demonstrated 19 cases of chordoma in which metastasis to adjacent dermis and subcutaneous adipose was observed. 9 Although adjacent cutaneous metastasis was observed in the presently described ferret, this case appears to be unique as a distant cutaneous metastasis was also observed. In 207 human chordoma cases, only 1 developed cutaneous metastases in a site other than overlying the primary tumor. 9 Chordomas in humans usually only metastasize after a long clinical period. 10 The chordoma in this ferret had been present for approximately 4 years. It is possible that the long clinical course in this case predisposed the ferret to developing metastases. In humans, the most common sites for metastases are the lungs, liver, and skeleton. 10 Because no necropsy was performed in this case, the development of metastases in these organs could not be excluded.
This ferret was reported to have had a small nodule at the base of her tail when she was purchased at 3 months of age. This initial nodule did not begin to enlarge until the ferret was 2.5 years of age. The mean age of chordoma development in a series of 20 ferrets was 3.4 years with the youngest animal 2.5 years of age. 1 Although the nodule that was present at 3 months of age was not examined histologically, it is interesting to speculate that this may have been a developmental defect that contained notochord tissue. When the ferret reached 2.5 years of age, this aberrant notochord tissue may have then undergone neoplastic transformation resulting in the slow growth of the neoplasm that was observed clinically.
Histologically, differential diagnoses in the currently described case included chordoma, poorly differentiated osteosarcoma and sebaceous gland carcinoma. A sebaceous carcinoma was considered less likely in this case because of the presence of well-differentiated trabeculae of bone. Although osseous metaplasia could be present in a sebaceous gland carcinoma, is appears unlikely to be such a significant component of the neoplasm. An osteosarcoma is expected to have significant quantities of bone. However, an osteosarcoma is not expected to contain such a significant population of large, vacuolated, mucin-producing cells. Bone or cartilage formation was reported previously to be present within 19 of 20 ferret chordomas that were removed from the tip of the tail. 1 Immunohistochemistry was used in this case to help differentiate a chordoma from a sebaceous gland carcinoma and an osteosarcoma. Vimentin expression is regarded as suggestive of mesenchymal cell origin, whereas cytokeratin is typically restricted to epithelial cells. 5 Cells within an osteosarcoma are expected to express vimentin but not cytokeratin. 5 Conversely, cells within a sebaceous gland carcinoma with osseous metaplasia may focally demonstrate vimentin immunoreactivity, but the majority of the neoplastic cells are expected to only express cytokeratin. 5 Chordomas are 1 of a small group of neoplasms in which the neoplastic cells express both proteins. 5 Neoplastic cells within both the primary coccygeal neoplasm and the subsequent skin masses reacted with antibodies against both vimentin and pancytokeratin. The histological appearance of the tumor, and the antigens expressed by the neoplastic cells, strongly suggest that all 3 tumors are chordomas.
Cell proliferation indices can predict the clinical behavior of some human and animal tumors. 2, 4 To investigate if such indices could predict the metastatic potential of ferret chordomas, cell proliferation indices within the currently described coccygeal neoplasm were compared with indices within 5 ferret chordomas that had been submitted to the AVDL in 2000 or 2001. These 5 chordomas had all been removed from the tip of the tail and had not shown evidence of tumor recurrence or metastases for at least 12 months. Signif-icant bone formation was present within all 5 chordomas. All 5 ferrets were either 6 or 7 years of age, and 6 months was the longest reported period between initial tumor observation and surgical removal. The cell proliferation indices measured were mitotic rate, AgNOR score, Ki-67 expression, and PCNA expression. All 6 chordomas had approximately 1 mitotic figure visible per ten 400ϫ fields. Within the chordoma that metastasized, 100 nuclei contained an average of 1.42 AgNORs. Nuclei from neoplastic cells within the other 5 chordomas contained 1.79 Ϯ 0.16 (mean Ϯ SD) AgNORs. Antibodies against Ki-67 stained 3 nuclei/100 cells within the chordoma that metastasized, whereas 4.4 Ϯ 3.7 (mean Ϯ SD) nuclei/100 cells stained within the other 5 chordomas. Six nuclei/100 cells reacted to anti-PCNA antibodies within the chordoma that metastasized, whereas 7 Ϯ 8.6 (mean Ϯ SD) nuclei/100 cells reacted to this antibody within the chordomas that exhibited benign clinical behavior. Using Winer's restriction criterion, 12 cell proliferation indices of the chordoma that metastasized were not outside the predicted range of values for the tumors that did not metastasize. Therefore, although the numbers of tumors compared was small, cell proliferation indices did not predict the metastatic potential of this tumor.
To the authors' knowledge, this is the first reported ferret coccygeal chordoma that developed at the base of the tail. In addition, this is the first report of a ferret chordoma that developed distant metastases. The cutaneous metastases behaved in a similar fashion to the primary tumor by demonstrating slow expansive growth. The observations from this case suggest that the metastatic potential of ferret chordomas may increase over a period of time. Therefore, prompt removal of these tumors may prevent subsequent metastatic disease. Additionally, a chordoma should be considered a differential diagnosis when examining a skin mass from a ferret that has previously developed a tumor of this type. Cell proliferation markers were not able to predict the metastatic potential of this tumor. However, because only 1 metastatic chordoma could be assessed, it is difficult to make firm conclusions about the use of these markers in tumors of this type.
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